Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimized Posterior Left Atrial Wall Ablation Strategy for Persistent Atrial Fibrillation: A Multicenter Large-Sample Clinical Study

NCT06633523 is registered in ClinicalTrials.gov with Shanghai Chest Hospital as lead sponsor.

NCT NCT06633523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06633523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimized Posterior Left Atrial Wall Ablation Strategy for Persistent Atrial Fibrillation: A Multicenter Large-Sample Clinical Study
Lead sponsor
Shanghai Chest Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2024
Completion date
January 1, 2026
Enrollment
384 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation